NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	21/12/2015
Target sample size	550
Countries of recruitment	Japan,Asia except Japan,North America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Avelumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Doxorubicin Therapeutic category code : 423 Antitumor antibiotics and preparations Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy confirmatory
Secondary Outcome	safety efficacy confirmatory exploratory pharmacokinetics pharmacodynamics

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Female
Include criteria
Exclude criteria